These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26316923)

  • 41. Comparison of point-of-care HbA1c test versus standardized laboratory testing.
    Sicard DA; Taylor JR
    Ann Pharmacother; 2005 Jun; 39(6):1024-8. PubMed ID: 15840733
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does use of point-of-care testing improve cost-effectiveness of the NHS Health Check programme in the primary care setting? A cost-minimisation analysis.
    El-Osta A; Woringer M; Pizzo E; Verhoef T; Dickie C; Ni MZ; Huddy JR; Soljak M; Hanna GB; Majeed A
    BMJ Open; 2017 Aug; 7(8):e015494. PubMed ID: 28814583
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Health care costs in people with diabetes and their association with glycemic control and kidney function.
    McBrien KA; Manns BJ; Chui B; Klarenbach SW; Rabi D; Ravani P; Hemmelgarn B; Wiebe N; Au F; Clement F
    Diabetes Care; 2013 May; 36(5):1172-80. PubMed ID: 23238665
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnosing diabetes mellitus: performance of hemoglobin A1c point-of-care instruments in general practice offices.
    Sølvik UØ; Røraas T; Christensen NG; Sandberg S
    Clin Chem; 2013 Dec; 59(12):1790-801. PubMed ID: 23958846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Agreement of Point-of-Care Capillary Glycated Hemoglobin Levels with Conventional Screening Tests for Diabetes Mellitus in a Canadian First Nations Population.
    Mackenzie-Feder J; Jin A; Seccombe DW; Sirrs S; Neufeld C; Dawson KG
    Can J Diabetes; 2016 Jun; 40(3):242-6. PubMed ID: 27026222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of a provincial intervention to reduce redundant hemoglobin A1c testing.
    Ma I; Guo M; Viczko J; Naugler C
    Clin Biochem; 2017 Dec; 50(18):1253-1255. PubMed ID: 28893597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA
    Abildgaard A; Knudsen CS; Bjerg LN; Lund S; Støy J
    Clin Chem Lab Med; 2022 Jan; 60(1):127-134. PubMed ID: 34480844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fetal hemoglobin and hemoglobin A1c level among pediatric patients with type 1 diabetes.
    Baranowska-Jaźwiecka AI; Mianowska B; Fendler W; Pomykała A; Młynarski W
    Pediatr Endocrinol Diabetes Metab; 2016; 22(2):48-53. PubMed ID: 28329772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implementation of POCT in the diabetic clinic in a large hospital.
    Tanyanyiwa D; Dandara C; Bhana SA; Pauly B; Marule F; Ramokoka M; Bwititi P; Nwose U; Nkosi B
    Afr Health Sci; 2015 Sep; 15(3):902-7. PubMed ID: 26957980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Haemoglobin A1c: evaluation of three point of care analysers for use in a paediatric diabetes clinic.
    Greaves RF; Northfield JA; Cameron FJ
    Ann Clin Biochem; 2005 Mar; 42(Pt 2):124-9. PubMed ID: 15829121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of Perioperative HbA1c on Reimbursements in Diabetes Mellitus Patients Undergoing Total Hip Arthroplasty: A Nationwide Analysis.
    Kurowicki J; Rosas S; Khlopas A; Newman JM; Law TY; Roche MW; Higuera CA; Mont MA
    J Arthroplasty; 2018 Jul; 33(7):2038-2042. PubMed ID: 29891083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glycated Hemoglobin and Methods for Its Point of Care Testing.
    Pohanka M
    Biosensors (Basel); 2021 Mar; 11(3):. PubMed ID: 33806493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quality of HbA1c Measurement in the Practice: The German Perspective.
    Heinemann L; Freckmann G
    J Diabetes Sci Technol; 2015 May; 9(3):687-95. PubMed ID: 25691655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Point-of-care testing for haemoglobin A1c in remote Australian Indigenous communities improves timeliness of diabetes care.
    Spaeth BA; Shephard MD; Schatz S
    Rural Remote Health; 2014; 14(4):2849. PubMed ID: 25359698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cost-effectiveness of testing strategies for type 2 diabetes: a modelling study.
    Gillett M; Brennan A; Watson P; Khunti K; Davies M; Mostafa S; Gray LJ
    Health Technol Assess; 2015 May; 19(33):1-80. PubMed ID: 25947106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pandemic-Associated Trends in Measurement of HbA1c in Children with Diabetes Mellitus and Validation of Dried Blood Spot as an Alternative Sample Matrix.
    Garnett ER; Recio B; Jung J; Tam E; Devaraj S
    Ann Clin Lab Sci; 2021 Jul; 51(4):535-539. PubMed ID: 34452892
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Indicators of glycemic control --hemoglobin A1c (HbA1c), glycated albumin (GA), and 1,5-anhydroglucitol (1,5-AG)].
    Sato A
    Rinsho Byori; 2014 Jan; 62(1):45-52. PubMed ID: 24724426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increasing Access to Diabetes Care in Underserved Populations Using Mobile Medicine: How Point-of-Care Testing on Mobile Clinics Strengthens Hemoglobin A1c Adherence in Vulnerable and Underserved Populations.
    Owen R; Wyckoff M; Rogers R
    J Dr Nurs Pract; 2021 Nov; 14(3):204-212. PubMed ID: 34963668
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Verification of a novel point-of-care HbA
    Wang Y; Peng W; Tang J; Dong L; Gu C; Zhang X; Zhou J; Jia W
    Biochem Med (Zagreb); 2018 Jun; 28(2):020705. PubMed ID: 29666558
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Temporal trends of hemoglobin A1c testing.
    Pivovarov R; Albers DJ; Hripcsak G; Sepulveda JL; Elhadad N
    J Am Med Inform Assoc; 2014; 21(6):1038-44. PubMed ID: 24928176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.